Out-licensing: Central Nervous System/Psychiatric

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 27 - per page Next page
Order by

In Vivo Non-Invasive Diagnostic Method Using Magnetic Resonance Spectroscopy of Aspartate Transaminase

A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More

Venlafaxin SR Caps 37.5-75-150 mg

Generic dossier More

Fluoxetine OroDispersible tablet 20 mg

Generic dossier More

Mirtazapine OroDispersible Tablet 15-30-45 mg

Generic dossier More

Generic version of Naltrexone 50 mg film tablet:

Opioid receptor blocker which reduces desire for opioids and alcohol, use in psychiatry, neurology and addition medicine. More

Butylcholinesterase-Binding Compounds for Monitoring and Inhibiting the Progression of Alzheimer's Disease

These radioactive compounds have the very unique and unprecedented ability to bind very specifically and irreversibly to butyrylcholinesterase (BChE). More

PITDC: Anti-depression pharmaceutical composition containing Polygala extract

Anti-depression More

Benztropinamine Analogs as Dopamine Transport Inhibitors

These analogs may increase water solubility and bioavailability for improved therapeutic formulation and utility More

Novel Benztropine Analogs for Treatment of Cocaine Abuse and Other Mental Disorders

These compounds have demonstrated high affinity and selectivity for the dopamine transporter over other monoamine transponders as well as muscarinic receptors, without a significant cocaine-like behavioral profile. More

Potent Pharmacophoric Delta- and Mu-Opioid Receptor Antagonists and Conversion of Endomorphin Mu-Opioid Agonists to Antagonists

This invention provides compositions for new modified opioid antagonists. More

Displaying 1..10 of 27 - per page Next page
Order by

Your selection

Therapeutic target: Central Nervous System del; Psychiatric del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Addiction; Alcoholism; Anorexia nervosa; Anxiety; Bipolar disorder; Bulimia nervosa; Cocaine addiction; Depression; Mental health (other); Obsessive compulsive disorder; Opioid dependency; Panic disorder; Phobia, social; Post-traumatic stress disorder; Psychosis; Schizophrenia
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us